In a letter to the U.S. Food and Drug Administration, the American Pain Society (APS, www.ampainsoc.org) petitioned the agency, on behalf of the terminally ill and their families, to modify a restricted distribution program for the newly approved pain medication Onsolis, a short acting product that delivers fentanyl through the mouth's mucous membranes.
More...
More...